+958.0%
MRNA vs UPRO
+502.1%
+456.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | UPRO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.9% | -3.9% | -4.6% |
| 7D | -20.9% | -11.5% | -9.4% | -18.1% |
| 30D | -13.3% | -15.4% | +2.2% | -8.9% |
| 3M | +212.6% | -16.9% | +229.5% | +231.5% |
| 6M | +309.0% | -9.7% | +318.7% | +323.9% |
| YTD | +567.3% | +9.0% | +558.3% | +557.9% |
| 1Y | +689.7% | +19.2% | +670.5% | +662.4% |
| 3Y | +157.4% | +174.1% | -16.7% | +102.8% |
| 5Y | -21.7% | +76.3% | -98.0% | -37.4% |
| All | +958.0% | +502.1% | +456.0% | +570.3% |
Cumulative growth
Daily Returns
Daily percentage return beside UPRO.
Daily Out/Under-Performance
Portfolio return minus UPRO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UPRO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded UPRO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling